Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycyline: Development and characterization

References

• Bigi A, Cojazzi G, Panzavolta S, Rubini K, Roveri N. Mechanical and thermal properties of gelatin films at different degrees of glutaraldehyde crosslinking. Biomaterials 2001; 22: 763–768
   PubMed Web of Science ®Google Scholar
• Bubnis WA, Ofner CM. The determination of ε-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometrie method using trinitrobenzenesulfonic acid. Analytical Biochemistry 1992; 207: 129–133
   PubMed Web of Science ®Google Scholar
• Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS. Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 2003; 15: 315–323
   Web of Science ®Google Scholar
• Choi YS, Lee SB, Hong SR, Lee YM, Song KW, Park MH, Nam YS. Studies on gelatin-based sponges. Part III: A comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat. Journal of Materials Science: Materials in Medicine 2001; 12: 67–73
   PubMed Web of Science ®Google Scholar
• Cortesi R, Esposito E, Osti M, Menegatti E, Squarzoni G, Davis SS, Nastruzzi C. Dextran cross-linked gelatin microspheres as a drug delivery system. European Journal of Pharmaceutics and Biopharmaceutics 1999; 47: 153–160
   PubMed Web of Science ®Google Scholar
• Digenis GA, Gold T, Shah VP. Crosslinking of gelatin capsules and its relevance to their in vitro-in vivo performance. Journal of Pharmaceutical Science 1994; 83: 915–921
   PubMed Web of Science ®Google Scholar
• Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinases-9, doxycycline and corticosteroids. American Journal of Ophthalmology 2001; 132: 8–13
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Nastruzzi C. Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials 1996; 17: 2009–2020
   PubMed Web of Science ®Google Scholar
• Gapski R, Barr JL, Sarment DP, Layher MG, Socransky SS, Giannobile WV. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: A proof of concept trial. Journal of Periodontology 2004; 75: 441–452
   PubMed Web of Science ®Google Scholar
• Jonas RA, Ziemer G, Schoen FJ, Britton L, Castaneda AR. A new sealant for knitted dacron prostheses: Minimally cross-linked gelatin. Journal of Vascular Surgery 1988; 7: 414–419
   PubMed Web of Science ®Google Scholar
• Kim HW, Kim HE, Salih V. Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials 2005; 26: 5221–5230
   PubMed Web of Science ®Google Scholar
• Kuijpers AJ, Engbers GHM, Wachem PB, Krijgsveld J, Zaat SAJ, Dankert J, Feijen J. Controlled delivery of antibacterial proteins from biodegradable matrices. Journal of Controlled Release 1998; 53: 235–247
   PubMed Web of Science ®Google Scholar
• Lee JM, Edwards HHL, Pereira CA, Samii SI. Crosslinking of tissue-derived biomaterials in 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC). Journal of Materials Science: Materials in Medicine 1996; 7: 531–535
   Web of Science ®Google Scholar
• Lee SB, Kim YH, Chong MS, Hong SH, Lee YM. Study of gelatin-containing artificial skin V: Fabrication of gelatin scaffolds using a salt-leaching method. Biomaterials 2005; 26: 1961–1968
   PubMed Web of Science ®Google Scholar
• Liang HC, Chang WH, Lin KJ, Sung HW. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: In vitro and in vivo studies. Journal of Biomedical Materials Research Part A 2003; 65A: 271–282
   Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunology Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Naimark WA, Pereira CA, Tsang K, Lee JM. HMDC crosslinking of bovine pericardial tissue: A potential role of the solvent environment in the design of bioprosthetic materials. Journal of Materials Science: Materials in Medicine 1995; 6: 235–241
   Web of Science ®Google Scholar
• Narayani R, Rao KP. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres. Journal of Microencapsulation 1994; 11: 69–77
   PubMed Web of Science ®Google Scholar
• Nordström D, Lindy O, Lauhio A, Sorsa T, Santavirta S, Konttinen YT. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatology International 1998; 17: 175–180
   PubMed Web of Science ®Google Scholar
• Olde Damink LHH, Dijkstra PJ, Van Luyn MJA, Van Wachem PB, Nieuwenhuis P, Feijen J. Crosslinking of dermal sheep collagen using water-soluble carbodiimide. Biomaterials 1996; 17: 765–773
   PubMed Web of Science ®Google Scholar
• Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJC. Matrix metalloproteinases. British Journal of Surgery 1997; 84: 160–166
   PubMed Web of Science ®Google Scholar
• Raymond G, Degennaro M, Mikeal R. Preparation of gelatin : phenytoin sodium microspheres: An in vitro and in vivo evaluation. Drug Developments in Industrial Pharmaceutics 1990; 16: 1025–1051
   Web of Science ®Google Scholar
• Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A, Cowled PA. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. European Journal of Vascular and. Endovascular Surgery 2002; 23: 260–269
   PubMed Web of Science ®Google Scholar
• Robert CCR, Buri PA, Peppas NA. Influence of the drug solubility and dissolution medium on the release from poly(2-hydroxyethylmethacrylate) microspheres. Journal of Controlled Release 1987; 5: 151–157
   Google Scholar
• Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Advanced Drug Delivery Reviews 2003; 55: 1679–1698
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram N, Sundaraseelan J, Uma S, Selvaraj D, Babu M. Design and delivery of silver sulfadiazine from alginate microspheres—impregnated collagen scaffold. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2006; 77B: 378–388
   Web of Science ®Google Scholar
• Sripriya R, Senthil Kumar M, Sehgal PK. Improved collagen bilayer dressing for the controlled release of drugs. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2004; 70B: 389–396
   Web of Science ®Google Scholar
• Sung HW, Huang DM, Chang WH, Huang RN, Hsu JC. Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: In vitro study. Journal of Biomedical Materials Research 1999; 46: 520–530
   PubMed Web of Science ®Google Scholar
• Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. Journal of Controlled Release 1994; 31: 111–214
   Web of Science ®Google Scholar
• Trengove NJ, Stacey MC, Macauley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair and Regeneration 1999; 7: 442–452
   PubMed Web of Science ®Google Scholar
• Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazinecream. Clinical Chemistry 1995; 41: 87–91
   PubMed Web of Science ®Google Scholar
• Ulubayram K, Cakar AN, Korkusuz P, Ertan C, Hasirci N. EGF containing gelatin-based wound dressings. Biomaterials 2001; 22: 1345–1356
   PubMed Web of Science ®Google Scholar
• Vandelli MA, Rivasi F, Guerra P, Forni F, Arletti R. Gelatin microspheres crosslinked with D,L- glyceraldehyde as a potential drug delivery system: Preparation, characterisation, in vitro and in vivo studies. International Journal of Pharmaceutics 2001; 215: 175–189
   PubMed Web of Science ®Google Scholar
• Welz MM, Ofner CM. Examination of self crosslinked gelatin as a hydrogel for controlled release system. Journal of Pharmaceutical Science 1992; 81: 85–89
   PubMed Web of Science ®Google Scholar
• Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair and Regeneration 1999; 7: 433–441
   PubMed Web of Science ®Google Scholar